Toggle light / dark theme

As the world fights the SARS-CoV-2 virus causing the COVID-19 pandemic, another group of dangerous pathogens looms in the background. The threat of antibiotic-resistant bacteria has been growing for years and appears to be getting worse. If COVID-19 taught us one thing, it’s that governments should be prepared for more global public health crises, and that includes finding new ways to combat rogue bacteria that are becoming resistant to commonly used drugs.

In contrast to the current pandemic, viruses may be be the heroes of the next epidemic rather than the villains. Scientists have shown that viruses could be great weapons against bacteria that are resistant to antibiotics.

I am a biotechnology and policy expert focused on understanding how personal genetic and biological information can improve human health. Every person interacts intimately with a unique assortment of viruses and bacteria, and by deciphering these complex relationships we can better treat infectious diseases caused by antibiotic-resistant bacteria.

The Future Of Food And Beverage Innovation And Venturing — Dr. Ellen De Brabander, Ph.D. — Senior Vice President, R&D, PepsiCo


Dr. Ellen de Brabander, is Senior Vice President, Research and Development, at PepsiCo, the American multinational food, snack, and beverage company.

Dr. de Brabander has broad set of responsibilities at Pepsico and currently leads their global R&D functions including the Food Safety, Quality, Strategy & Portfolio Management, and their Sensory and Regulatory Affairs teams. She also leads their R&D Digital Transformation initiatives to transform the innovation process to bring new, innovative products to the market.

Dr. de Brabander is also a member of the board of governors at the New York Academy of Sciences and has served as Treasurer and board member International Life Science Institute of North America, an organization that brings together scientists from government, academia and industry to uphold the scientific integrity and objectivity of nutrition and food safety science in order to ethically improve food systems for the betterment of public health.

Additionally, Dr. de Brabander has also served as the interim and founding CEO of EIT Food (part of the EU’s European Institute of Innovation and Technology), which is a unique $1.5 Billion Euro innovation consortium with more than 50 partners from industry and academia, focused on transforming the food sector by designing and delivering unique and high impact research, innovation, business creation and education programs.

Join us for Dr. Matt Kaeberlein’s presentation. He is the Founding Director of the UW Healthy Aging and Longevity Research Institute, and founder and co-Director of the Dog Aging Project and a Professor of Laboratory Medicine and Pathology at the University of Washington (UW) School of Medicine, with Adjunct appointments in Genome Sciences and Oral Health Sciences. Dr. Kaeberlein’s research interests are focused on biological mechanisms of aging in order to facilitate translational interventions that promote healthspan and improve quality of life.

“Our task is to make nature, the blind force of nature, into an instrument of universal resuscitation and to become a union of immortal beings.“
- Nikolai F. Fedorov.

We hold faith in the technologies & discoveries of humanity to END AGING and Defeat involuntary Death within our lifetime.

Working to Save Lives with Age Reversal Education.

========== Perpetual Life Creed ==========

We believe that all of life is sacred and that we have been given this one life to make unlimited. We believe in our Creator’s divine plan for all of humanity to have infinite lifespans in perfect health and eternal joy, rendering death to be optional.

Code of the Wild (Documentary) at Hello Tomorrow in Paris.

www.codeofthewild.org to watch the trailer and explore the film.

George Church, Antonio Regalado, and Josiah Zayner discuss designer babies, moratorium on human germ line engineering, and the future of the genomic revolution with Jane Metcalfe, co-founder of Wired Magizine and founder of Neolife (https://neo.life/)

___________________
CONNECT WITH US:
codeofthewild.org.
facebook.com/CodeoftheWild.
@CodeoftheWild (twitter)
@CodeoftheWild (Instagram)

Produced By.
www.RhumblineMedia.com.
Cody Sheehy.
Samira Kiani

Hallucinogens, neuro-immunology and the microbiome — convergent approaches in mental healthcare — mike wang, johns hopkins university.


Mike Wang, is a neuro-psychiatric researcher and adjunct teaching faculty in neuroscience at the Johns Hopkins Krieger School of Arts and Sciences.

Mike is one of the youngest principal investigators at the Johns Hopkins School of Medicine and currently leads a clinical trial examining how hallucinogenic levels of over-the-counter dextromethorphan might serve as the world’s first rapid acting oral antidepressant. (Those interested in the clinical trial for dextromethorphan can.

Mike’s work has been featured in academic journals like the American Journal of Psychiatry, as well as popular outlets like Psychology Today and VICE.

Mike received his graduate training in immunology at the Johns Hopkins Bloomberg School of Public Health studying rare viral encephalitides and neuro-immune determinants of depressive disorders.